Status:
ACTIVE_NOT_RECRUITING
Performance Study with the SiMoT System for in Vitro Diagnostic Tests
Lead Sponsor:
Centro di Innovazione Regionale in Single Molecule Digital Assay
Conditions:
Non-interventional Analytical Performance Study on Left-over Samples
Eligibility:
All Genders
18+ years
Brief Summary
Advanced and performing technologies able to analyze specific biomarkers for the diagnosis, prognosis and prediction as well as for the monitoring, the personalized care and the evaluation of the ther...
Detailed Description
Advanced and performing technologies able to analyze specific biomarkers for the diagnosis, prognosis and prediction as well as for the monitoring, the personalized care and the evaluation of the ther...
Eligibility Criteria
Inclusion
- Informed Consent and personal data handling consent signed by the subject;
- \> 18 years of age
- presence of neoplastic or suspected neoplastic pathology at the time of sample collection
Exclusion
- \< 18 years of age
- Participation in a clinical trial with an investigational drug or a medical device within the 30 days preceding and during the present investigation.
Key Trial Info
Start Date :
July 16 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06518967
Start Date
July 16 2024
End Date
May 31 2025
Last Update
February 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Istituto Tumori Giovanni Paolo II, Gynecological Oncologic Clinic
Bari, Bari, Italy, 70124